BioScience Health Innovations, Inc.
BHIC
$4.49
$0.4912.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -658.10K | -14.60K | 642.10K | 885.70K | 950.70K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.00K | -48.10K | -61.20K | -- | -- |
| Change in Net Operating Assets | -842.00K | -645.50K | -408.70K | -663.20K | -335.50K |
| Cash from Operations | -1.54M | -708.20K | 172.20K | 222.60K | 615.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.80K | -26.90K | -56.90K | -65.10K | -72.10K |
| Cash from Investing | -37.80K | -26.90K | -56.90K | -65.10K | -72.10K |
| Total Debt Issued | 2.40M | 3.20M | 3.05M | 2.69M | 1.94M |
| Total Debt Repaid | -2.19M | -2.79M | -3.16M | -2.50M | -1.90M |
| Issuance of Common Stock | 773.30K | 437.10K | -- | 455.00K | 580.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 985.90K | 851.80K | -115.90K | 648.70K | 612.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -587.00K | 116.70K | -600.00 | 806.20K | 1.16M |